Japanese conglomerate bets $68M on Indian API maker

Japanese corporate giant Mitsui likes what it sees in the Indian CMO market, deciding to buy a nearly 30% stake in API manufacturer Arch Pharmalabs for $68 million. "As demand for generic drugs grows, there is a pronounced trend among generic drug manufacturers to use CMOs in India," Mitsui said in a statement. The investment has cleared India's Competition Commission, a body that has in the past considered halting foreign investments in domestic pharma companies. Report

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.